KW-3902
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for KW-3902, covering 2008-01-29 to 2009-10-09. Get the full timeline:
Most recent: Clinical Trial Update: PROTECT-2: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function [Phase 3]